» Articles » PMID: 36354664

Anti-Inflammatory and Hypouricemic Effect of Bioactive Compounds: Molecular Evidence and Potential Application in the Management of Gout

Overview
Publisher MDPI
Specialty Molecular Biology
Date 2022 Nov 10
PMID 36354664
Authors
Affiliations
Soon will be listed here.
Abstract

Gout is caused by the deposition of monosodium urate crystals in the joint and represents the most common form of inflammatory arthritis in men. Its prevalence is rising worldwide mainly due to the increase of risk factors associated with the disease, in particular hyperuricemia. Besides gout, hyperuricemia leads to an increased inflammatory state of the body with consequent increased risk of comorbidities such as cardiovascular diseases. Increasing evidence shows that bioactive compounds have a significant role in fighting inflammatory and immune chronic conditions. In gout and hyperuricemia, these molecules can exert their effects at two levels. They can either decrease serum uric acid concentrations or fight inflammation associated with monosodium urate crystals deposits and hyperuricemia. In this view, they might be considered valuable support to the pharmacological therapy and prevention of the disease. This review aims to provide an overview of the beneficial role of bioactive compounds in hyperuricemia, gout development, and inflammatory pathways of the disease.

Citing Articles

Subclinical Atherosclerosis in a Gout Cohort: Prevalence and Associations.

Parvanescu C, Barbulescu A, Dinescu S, Bita C, Firulescu S, Trasca B Curr Health Sci J. 2024; 50(2):274-282.

PMID: 39371056 PMC: 11447497. DOI: 10.12865/CHSJ.50.02.13.


Triterpenes Drug Delivery Systems, a Modern Approach for Arthritis Targeted Therapy.

Faustino C, Duarte N, Pinheiro L Pharmaceuticals (Basel). 2024; 17(1).

PMID: 38256888 PMC: 10819636. DOI: 10.3390/ph17010054.


Lignan and Phthalide Derivatives from the Rhizome of () and Evaluation of Their -Xanthine Oxidase Activities.

Yang M, Yang H, Tang Z, Hu X, Zhou R, Xue T ACS Omega. 2023; 8(42):39855-39864.

PMID: 37901529 PMC: 10601418. DOI: 10.1021/acsomega.3c06172.


An elevated likelihood of stroke, ischemic heart disease, or heart failure in individuals with gout: a longitudinal follow-up study utilizing the National Health Information database in Korea.

Kang H, Lee N, Yoo D, Han K, Hong J, Choi H Front Endocrinol (Lausanne). 2023; 14:1195888.

PMID: 37680887 PMC: 10482324. DOI: 10.3389/fendo.2023.1195888.


Bioactives and Inflammation.

Liu G, Kuo C Curr Issues Mol Biol. 2023; 45(7):5824-5829.

PMID: 37504284 PMC: 10377902. DOI: 10.3390/cimb45070368.


References
1.
Lamb K, Lynn A, Russell J, Barker M . Effect of tart cherry juice on risk of gout attacks: protocol for a randomised controlled trial. BMJ Open. 2020; 10(3):e035108. PMC: 7073821. DOI: 10.1136/bmjopen-2019-035108. View

2.
Li X, Jin W, Zhang W, Zheng G . The inhibitory kinetics and mechanism of quercetin-3-O-rhamnoside and chlorogenic acid derived from Smilax china L. EtOAc fraction on xanthine oxidase. Int J Biol Macromol. 2022; 213:447-455. DOI: 10.1016/j.ijbiomac.2022.05.188. View

3.
Mehmood A, Zhao L, Wang C, Hossen I, Raka R, Zhang H . Stevia residue extract increases intestinal uric acid excretion via interactions with intestinal urate transporters in hyperuricemic mice. Food Funct. 2019; 10(12):7900-7912. DOI: 10.1039/c9fo02032b. View

4.
de Souza M, de Paula C, Pereira de Resende M, Grabe-Guimaraes A, de Souza Filho J, Saude-Guimaraes D . Pharmacological basis for use of Lychnophora trichocarpha in gouty arthritis: anti-hyperuricemic and anti-inflammatory effects of its extract, fraction and constituents. J Ethnopharmacol. 2012; 142(3):845-50. DOI: 10.1016/j.jep.2012.06.012. View

5.
Dhanasekar C, Kalaiselvan S, Rasool M . Morin, a Bioflavonoid Suppresses Monosodium Urate Crystal-Induced Inflammatory Immune Response in RAW 264.7 Macrophages through the Inhibition of Inflammatory Mediators, Intracellular ROS Levels and NF-κB Activation. PLoS One. 2015; 10(12):e0145093. PMC: 4692533. DOI: 10.1371/journal.pone.0145093. View